NCT00106704View on ClinicalTrials.gov

Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)

PHASE3CompletedINTERVENTIONAL
Enrollment

441

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

January 31, 2007

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Comparator: Sitagliptin

sitagliptin 10 mg tablet, once daily for 54 weeks

DRUG

Comparator: Placebo

Placebo oral tablet once daily for 24 weeks

DRUG

Comparator: Pioglitazone

Pioglitazone 30 mg tablet once daily for 30 weeks

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00106704 - Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035) | Biotech Hunter | Biotech Hunter